Peptide class
GLP-1, GIP and glucagon receptor research
Research context around incretin and metabolic receptor agonists such as semaglutide, tirzepatide, retatrutide and cagrilintide.
Compiled from batch documentation, COA/SDS checks and peer-reviewed literature. Content is intended as research-only technical documentation.
Important
Research Use Only. This information is intended for laboratory context and does not include dosing, administration advice, or claims for human or veterinary use.
Receptor families
GLP-1, GIP and glucagon are signalling routes often studied separately or together in metabolic research. Dual and triple agonist models are used to compare receptor selectivity and signalling balance.
Analytical considerations
For this class, exact vial content, batch linkage and purity reporting are important because small differences in starting material can affect interpretation.
Boundaries
This page describes receptor research in vitro or in controlled research models. It does not provide information for weight loss, treatment, dosing or personal use.
Primary sources & literature
External literature and databases for checking claims, identity and analytical methods. Always verify batch-specific details against COA/SDS.
PubMed
Full-length human GLP-1 receptor structure without orthosteric ligands
PubMed
Structural basis for GLP-1 receptor activation by LY3502970
PubMed
Retatrutide phase 2 literature
PubMed
Retatrutide literature
PubMed
Tirzepatide literature
PubMed